Breaking News on Global Pharmaceutical Technology & Manufacturing

Constantia buys Tobepal from Amcor

22-Jul-2010 - Austria’s Constantia Packaging will pay Amcor €92m ($118m) for its Spanish Tobepal flexible packaging business.

Merck Millipore launched after $7bn takover

19-Jul-2010 - Germany’s Merck KGaA has completed its $7bn (€b5.2n) acquisition of Millipore, unveiling plans to target “high-growth, high-margin” bio-research and bio-production markets.

Guest article

M&A processes, pitfalls and keys to success

15-Jul-2010 - M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes...

Merck to close eight production facilities, eight R&D labs

12-Jul-2010 - Merck & Co is to close or sell eight manufacturing plants and a further eight R&D laboratories as part of efforts to cuts its workforce by 15 per cent.

Sanofi said to be planning $20bn acquisition in US

05-Jul-2010 - Rumour has it that French drug giant Sanofi Aventis is planning to make a $20bn (€16bn) acquisition in the US with speculation that biotechs like Allergan, Biogen Idec and Genzyme...

Abbott exploring sale of vaccines unit

05-Jul-2010 - Abbott Laboratories has confirmed it is considering the sale of the vaccines unit it gained with the €4.5bn ($6.2bn) acquisition of Solvay Pharmaceuticals in February .

Alembic to demerge pharma business

30-Jun-2010 - India’s oldest pharmaceutical company Alembic went one step closer to the biggest restructuring in its history as its board approved the demerging of its main pharmaceutical business into a separate...

Sosei buys Activus Pharma and drug delivery technology

29-Jun-2010 - Sosei has revealed its intention to acquire Activus Pharma in a deal which allows the Japan-based firm to get their hands on Activus' nanoparticle drug formulation tools, a technology that’s...

Gilead buys a $120m ticket for protein kinase research role

28-Jun-2010 - A deal to broaden Gilead’s research expertise into protein kinase biology has been finalised with the $120m acquisition of CGI Pharmaceuticals, in a deal that compliments its comprehensive selection of...

News in brief

Biovail and Valeant to merge

23-Jun-2010 - Canada’s Biovail plans to buy Valeant Pharmaceuticals to strengthen US position in specialty CNS, dermatology and generics markets.

Minapharm buys CMO ProBioGen for €30.4m

17-Jun-2010 - Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).

Interactive Quiz

US industry quiz – how much do you know about H1 2010?

11-Jun-2010 - Know your Lilly from your Lonza? Then test your industry knowledge against colleagues, peers and our community of readers by participating in our exclusive map-based quiz.

Surya raising funds to invest in production capacity

02-Jun-2010 - India-based Surya Pharmaceuticals is planning to raise Rs 500 crore ($100m) to fund construction of an active pharmaceutical ingredient (API) production plant, according to local media reports.

Financial climate better for potential delivery unit sale, says Elan

01-Jun-2010 - Irish pharmaceutical company Elan says most potential investors are positive about proposal to spin-off drug delivery unit.

Adcock plans expansions & acquisitions to drive growth

26-May-2010 - Adcock Ingram recorded an 11 per cent rise in profit in the first half of 2010 and is looking to continue this upwards trend through manufacturing expansions, plus local and overseas acquisitions.

Invida buys in Indonesia to gain local production presence

24-May-2010 - Invida has acquired a stake in Indonesia-based MUGI, giving it the local manufacturing presence needed to offer partners access to “a vast untapped market”.

News in brief

Is Sanofi looking at Piramal again?

19-May-2010 - Rumours have resurfaced that Indian generics firm Piramal Healthcare is in talks with Sanofi-Aventis and Pfizer about a potential takeover.

Pfizer to close 8 sites, cut ops at 6 more; 6,000 jobs to go

19-May-2010 - Pfizer plans to close eight manufacturing sites and reduce operations at a further six by the end of 2015, leading to 6,000 job losses, as part of its reorganisation after acquiring Wyeth.

Millipore Q1 revs up 14% on pharma spending

10-May-2010 - Millipore says that rebounding Big Pharma spending and biotechnology drove first-quarter 2010 gains.

DSM buys Upfront's Rhobust chromatography tech

05-May-2010 - DSM Biologics says combining its XD platform with newly-acquired Rhobust chromatography platform will create high yield, low cost bio-manufacturing option.

Comar builds capacity with Unicon buy

27-Apr-2010 - US drug packaging firm Comar says acquisition of Universal Container Corp (Unicon) provides capacity for growth, particularly in key liquid medication delivery device market.

AMPAC opens new Texas API plant

19-Apr-2010 - AMPAC Fine Chemicals boosts reactor capacity 30 per cent with new manufacturing plant and says North America is attractive for API production.

Has Hospira beaten Myriad in Javelin competition?

13-Apr-2010 - US drugmaker Javelin Pharmaceuticals says Hospira’s takeover bid is “superior” and terminates agreement with Myriad Pharmaceuticals (MPI).

Dainippon expands RNAi delivery deal with Silence Therapeutics

31-Mar-2010 - Silence Therapeutics says extension of RNAi drug delivery collaboration by Dainippon Sumitomo is evidence of technology’s potential.

Schott posts fiscal 09 loss, but predicts double-digit growth

23-Mar-2010 - Industrial glass maker Schott ended a “rather difficult” fiscal 2009 with a loss but says rise in drug packaging sales will help drive double-digit earnings growth in current financial year.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...